Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 1
2014 1
2015 1
2017 1
2018 1
2019 3
2020 2
2023 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer.
Umemoto K, Sunakawa Y, Ueno M, Furukawa M, Mizuno N, Sudo K, Kawamoto Y, Kajiwara T, Ohtsubo K, Okano N, Matsuhashi N, Itoh S, Matsumoto T, Shimizu S, Otsuru T, Hasegawa H, Okuyama H, Ohama H, Moriwaki T, Ohta T, Odegaard JI, Nakamura Y, Bando H, Yoshino T, Ikeda M, Morizane C. Umemoto K, et al. Among authors: otsuru t. Br J Cancer. 2023 Apr;128(8):1603-1608. doi: 10.1038/s41416-023-02189-y. Epub 2023 Feb 13. Br J Cancer. 2023. PMID: 36782009 Free PMC article.
Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancer.
Nishigaki T, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Hara H, Sugase T, Otsuru T, Saito Y, Tsujii S, Nomura T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Nakajima K, Eguchi H, Yamasaki M, Mori M, Doki Y, Naka T. Nishigaki T, et al. Among authors: otsuru t. Br J Cancer. 2020 Apr;122(9):1333-1341. doi: 10.1038/s41416-020-0781-2. Epub 2020 Mar 10. Br J Cancer. 2020. PMID: 32152502 Free PMC article.
Nivolumab-induced interstitial lung disease in a patient with gastric cancer.
Kimura A, Sakai D, Kudo T, Nishida N, Katou A, Inagaki C, Otsuru T, Miyazaki Y, Tanaka K, Makino T, Takahashi T, Kurokawa Y, Yamasaki M, Mori M, Doki Y, Satoh T. Kimura A, et al. Among authors: otsuru t. Oxf Med Case Reports. 2019 Feb 27;2019(2):omz007. doi: 10.1093/omcr/omz007. eCollection 2019 Feb. Oxf Med Case Reports. 2019. PMID: 30863551 Free PMC article.
Epithelial-mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine-rich alpha-2 glycoprotein.
Otsuru T, Kobayashi S, Wada H, Takahashi T, Gotoh K, Iwagami Y, Yamada D, Noda T, Asaoka T, Serada S, Fujimoto M, Eguchi H, Mori M, Doki Y, Naka T. Otsuru T, et al. Cancer Sci. 2019 Mar;110(3):985-996. doi: 10.1111/cas.13918. Epub 2019 Feb 4. Cancer Sci. 2019. PMID: 30575211 Free PMC article.
Chemotherapy-induced neutropenia as a prognostic factor in patients with pancreatic cancer treated with gemcitabine plus nab-paclitaxel: a retrospective cohort study.
Kan M, Imaoka H, Watanabe K, Sasaki M, Takahashi H, Hashimoto Y, Ohno I, Mitsunaga S, Umemoto K, Kimura G, Suzuki Y, Eguchi H, Otsuru T, Goda K, Ikeda M. Kan M, et al. Among authors: otsuru t. Cancer Chemother Pharmacol. 2020 Aug;86(2):203-210. doi: 10.1007/s00280-020-04110-3. Epub 2020 Jul 6. Cancer Chemother Pharmacol. 2020. PMID: 32632515 Clinical Trial.
Expression of carbonic anhydrase IX is associated with poor prognosis through regulation of the epithelial‑mesenchymal transition in hepatocellular carcinoma.
Hyuga S, Wada H, Eguchi H, Otsuru T, Iwgami Y, Yamada D, Noda T, Asaoka T, Kawamoto K, Gotoh K, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M. Hyuga S, et al. Among authors: otsuru t. Int J Oncol. 2017 Oct;51(4):1179-1190. doi: 10.3892/ijo.2017.4098. Epub 2017 Aug 22. Int J Oncol. 2017. PMID: 28849188
A multicenter prospective observational study for health assessment questionnaires EQ-5D-5L and G8 in unresectable advanced pancreatic cancer treated with first-line gemcitabine plus nab-paclitaxel therapy.
Hino K, Nishina T, Koizumi M, Marui K, Kokubu M, Numata Y, Imamura Y, Kanemitsu-Okada K, Otsuru T, Kuroda T, Ohno Y, Asagi A, Miyata H, Yokota T, Kumagi T, Hyodo I, Ikeda Y, Hiasa Y. Hino K, et al. Among authors: otsuru t. Int J Clin Oncol. 2025 Apr;30(4):738-748. doi: 10.1007/s10147-025-02717-1. Epub 2025 Feb 27. Int J Clin Oncol. 2025. PMID: 40011378
13 results